Search Results - "MURRAY, Bernard P"

Refine Results
  1. 1
  2. 2
  3. 3

    Regional proteomic quantification of clinically relevant non-cytochrome P450 enzymes along the human small intestine by Zhang, Haeyoung, Wolford, Chris, Basit, Abdul, Li, Albert P, Fan, Peter W, Takahashi, Ryan H, Khojasteh, S Cyrus, Smith, Bill J, Murray, Bernard P, Thummel, Kenneth, Prasad, Bhagwat

    Published in Drug metabolism and disposition (01-07-2020)
    “…Current challenges in accurately predicting intestinal metabolism arise from the complex nature of the intestine, leading to limited applicability of available…”
    Get full text
    Journal Article
  4. 4

    Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer by Xu, Lianhong, Liu, Hongtao, Murray, Bernard P, Callebaut, Christian, Lee, Melody S, Hong, Allen, Strickley, Robert G, Tsai, Luong K, Stray, Kirsten M, Wang, Yujin, Rhodes, Gerry R, Desai, Manoj C

    Published in ACS medicinal chemistry letters (12-08-2010)
    “…Cobicistat (3, GS-9350) is a newly discovered, potent, and selective inhibitor of human cytochrome P450 3A (CYP3A) enzymes. In contrast to ritonavir, 3 is…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Assessing Pleiotropic Effects of a Mixed-Mode Perpetrator Drug, Rifampicin, by Multiple Endogenous Biomarkers in Dogs by Liu, Renmeng, Ma, Bin, Mok, Marilyn M, Murray, Bernard P, Subramanian, Raju, Lai, Yurong

    Published in Drug metabolism and disposition (14-02-2024)
    “…Rifampicin (RIF) is a mixed-mode perpetrator that produces pleiotropic effects on liver cytochrome P450 enzymes and drug transporters. To assess the complex…”
    Get full text
    Journal Article
  10. 10

    Comparison of Tissue Abundance of Non-Cytochrome P450 Drug-Metabolizing Enzymes by Quantitative Proteomics between Humans and Laboratory Animal Species by Basit, Abdul, Fan, Peter W, Khojasteh, S Cyrus, Murray, Bernard P, Smith, Bill J, Heyward, Scott, Prasad, Bhagwat

    Published in Drug metabolism and disposition (01-03-2022)
    “…The use of animal pharmacokinetic models as surrogates for humans relies on the assumption that the drug disposition mechanisms are similar between preclinical…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Dissecting Parameters Contributing to the Underprediction of Aldehyde Oxidase-Mediated Metabolic Clearance of Drugs by Subash, Sandhya, Singh, Dilip K, Ahire, Deepak S, Khojasteh, S Cyrus, Murray, Bernard P, Zientek, Michael A, Jones, Robert S, Kulkarni, Priyanka, Smith, Bill J, Heyward, Scott, Cronin, Ciarán N, Prasad, Bhagwat

    Published in Drug metabolism and disposition (01-10-2023)
    “…We investigated the effect of variability and instability in aldehyde oxidase (AO) content and activity on the scaling of in vitro metabolism data. AO content…”
    Get full text
    Journal Article
  14. 14

    Ontogeny of Human Liver Aldehyde Oxidase: Developmental Changes and Implications for Drug Metabolism by Subash, Sandhya, Singh, Dilip K., Ahire, Deepak, Khojasteh, S. Cyrus, Murray, Bernard P., Zientek, Michael A., Jones, Robert S., Kulkarni, Priyanka, Zubair, Faizan, Smith, Bill J., Heyward, Scott, Leeder, J. Steven, Prasad, Bhagwat

    Published in Molecular pharmaceutics (08-05-2024)
    “…Despite the increasing importance of aldehyde oxidase (AO) in the drug metabolism of clinical candidates, ontogeny data for AO are limited. The objective of…”
    Get full text
    Journal Article
  15. 15

    Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite-Resolution for Clinical Development by Zheng, Jim, Xin, Yan, Zhang, Jingyu, Subramanian, Raju, Murray, Bernard P, Whitney, J Andrew, Warr, Matthew R, Ling, John, Moorehead, Lisa, Kwan, Ellen, Hemenway, Jeffrey, Smith, Bill J, Silverman, Jeffrey A

    Published in Drug metabolism and disposition (01-03-2018)
    “…Momelotinib (MMB), a small-molecule inhibitor of Janus kinase (JAK)1/2 and of activin A receptor type 1 (ACVR1), is in clinical development for the treatment…”
    Get full text
    Journal Article
  16. 16

    Vacuolar degradation of rat liver CYP2B1 in Saccharomyces cerevisiae: further validation of the yeast model and structural implications for the degradation of mammalian endoplasmic reticulum P450 proteins by Liao, Mingxiang, Zgoda, Victor G, Zgoda, Victor A, Murray, Bernard P, Correia, Maria Almira

    Published in Molecular pharmacology (01-05-2005)
    “…Mammalian hepatic cytochromes P450 (P450s) are endoplasmic reticulum (ER)-anchored hemoproteins with highly variable half-lives. CYP3A4, the dominant human…”
    Get more information
    Journal Article
  17. 17

    Effects of GS-9876, a novel spleen tyrosine kinase inhibitor, on platelet function and systemic hemostasis by Clarke, Astrid S., Rousseau, Emma, Wang, Kelly, Kim, Ji-Yun, Murray, Bernard P., Bannister, Roy, Matzkies, Franziska, Currie, Kevin S., Di Paolo, Julie A.

    Published in Thrombosis research (01-10-2018)
    “…Spleen tyrosine kinase (SYK) mediates signal transduction in multiple hematopoietic cells, including platelets. SYK signals downstream of immunoreceptors and…”
    Get full text
    Journal Article
  18. 18

    The Drug–Drug Interaction Profile of Presatovir by Xin, Yan, Weng, Winnie, Murray, Bernard P., Eisenberg, Eugene J., Chien, Jason W., Ling, John, Silverman, Jeffrey A.

    Published in Journal of clinical pharmacology (01-06-2018)
    “…Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in young children. Presatovir (previously GS‐5806) is a novel, orally…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Native CYP2C11: heterologous expression in Saccharomyces cerevisiae reveals a role for vacuolar proteases rather than the proteasome system in the degradation of this endoplasmic reticulum protein by Murray, Bernard P, Zgoda, Victor G, Correia, Maria Almira

    Published in Molecular pharmacology (01-05-2002)
    “…Cytochromes P450 (P450s) are hemoprotein enzymes committed to the metabolism of chemically diverse endo- and xenobiotics. They are anchored to the endoplasmic…”
    Get more information
    Journal Article